The company's financial position appears vulnerable, with a limited $2.3 million cash reserve that may constrain operational runway within the next 12 to 18 months.
| Metric | Apr'24 | Apr'23 |
|---|
| Total Current Assets | 4.73M | 909.3K |
| Cash & Short-Term Investments | 2.31M | 54.1K |
| Cash Only | 2.31M | 54.1K |
| Short-Term Investments | 0 | 0 |
| Accounts Receivable | 1.94M | 567.03K |
| Days Sales Outstanding | 376.78 | 318.02 |
| Inventory | 187.58K | 151.52K |
| Days Inventory Outstanding | 69.5 | 103.15 |
| Other Current Assets | 225.7K | 20.04K |
| Total Non-Current Assets | 451.45K | 473.07K |
| Property, Plant & Equipment | 451.45K | 473.07K |
| Fixed Asset Turnover | 4.17x | 1.38x |
| Goodwill | 0 | 0 |
| Intangible Assets | 0 | 0 |
| Long-Term Investments | 0 | 0 |
| Other Non-Current Assets | 0 | 0 |
| Total Assets | 5.18M | 1.38M |
| Asset Turnover | 0.36x | 0.47x |
| Asset Growth % | 275.05% | - |
| Total Current Liabilities | 2.05M | 3.75M |
| Accounts Payable | 293.91K | 91.09K |
| Days Payables Outstanding | 108.9 | 62.01 |
| Short-Term Debt | 440.45K | 143.35K |
| Deferred Revenue (Current) | 0 | 0 |
| Other Current Liabilities | 32K | 32K |
| Current Ratio | 2.31x | 0.24x |
| Quick Ratio | 2.22x | 0.20x |
| Cash Conversion Cycle | 337.39 | 359.16 |
| Total Non-Current Liabilities | 219.34K | 651.68K |
| Long-Term Debt | 133.98K | 574.56K |
| Capital Lease Obligations | 85.36K | 77.12K |
| Deferred Tax Liabilities | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 |
| Total Liabilities | 2.26M | 4.4M |
| Total Debt | 792.58K | 885.35K |
| Net Debt | -1.52M | 831.26K |
| Debt / Equity | 0.27x | - |
| Debt / EBITDA | - | - |
| Net Debt / EBITDA | - | - |
| Interest Coverage | -57.49x | -81.47x |
| Total Equity | 2.92M | -3.02M |
| Equity Growth % | 196.79% | - |
| Book Value per Share | - | -1.12 |
| Total Shareholders' Equity | 2.92M | -3.02M |
| Common Stock | 3.49K | 2.65K |
| Retained Earnings | -7.03M | -4.67M |
| Treasury Stock | 0 | 0 |
| Accumulated OCI | 0 | 0 |
| Minority Interest | 0 | 0 |
Limited liquidity runway
As indicated by the company's financial profile, the balance sheet trajectory appears increasingly strained as the firm relies on equity-funded growth to offset significant operating losses, leaving the overall financial position vulnerable to shifts in investor sentiment or delays in achieving commercial scale for its Optonano line.
The absence of meaningful debt suggests that the company has yet to establish the creditworthiness required for traditional financing, forcing a reliance on dilutive capital. This trajectory indicates that the business quality remains highly speculative until the company can demonstrate a path toward self-funding its operational requirements.
Based on reported figures, the company's $2.3 million cash position provides a narrow buffer against its high operating burn rate, suggesting that liquidity may become a critical constraint within the next 12 to 18 months if revenue growth does not translate into positive operating cash flow.
The current liquidity position appears insufficient to support long-term R&D and manufacturing scaling without further external capital injections. Investors should monitor the cash burn rate closely, as any deviation from the current growth trajectory could necessitate emergency financing that may significantly dilute existing shareholders.
According to financial disclosures, the company's equity base is primarily composed of paid-in capital rather than retained earnings, reflecting a business model that is currently consuming shareholder value to fund its aggressive expansion into the industrial metrology and biomedical imaging markets.
The reliance on equity funding highlights the lack of internal capital generation, which is typical for early-stage hardware firms but poses a risk to long-term equity quality. The absence of retained earnings suggests that the company has not yet reached the maturity required to provide a stable return on invested capital.
As noted in recent intelligence, the balance sheet may be distorted by the potential capitalization of R&D costs, which warrants further investigation to determine if the reported asset base accurately reflects the underlying economic value of the company's proprietary microsphere lensing technology.
If the company is aggressively capitalizing development expenses, the headline asset figures may be overstated, masking the true extent of the cash burn. Investors should be cautious of potential goodwill or intangible asset impairment risks if the Optonano product line fails to achieve expected market penetration in the competitive electronics manufacturing sector.
Quick answers to the most common questions about buying POAS stock.
As of 2023, Phaos Technology Holdings (Cayman) Limited (POAS) had total assets of $5.2M including $4.7M in current assets.
Phaos Technology Holdings (Cayman) Limited (POAS) carries total debt of $0.8M, offset by $2.3M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Phaos Technology Holdings (Cayman) Limited (POAS) has total shareholders' equity (book value) of $2.9M. Book value represents the net worth of the company belonging to common stock holders.
Phaos Technology Holdings (Cayman) Limited (POAS) reported a current ratio of 2.31x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.